Diane Lifton

Diane Lifton has served as Enzyvant’s lead corporate attorney since August 2020. She brings more than 25 years of experience providing legal advice to life sciences companies, supporting senior leaders on key areas of drug development, commercialization, compliance, corporate governance, IP portfolio strategy, strategic partnering and business transactions.

Diane holds a Juris Doctorate from the University of Michigan Law School, a Bachelor of Arts in Government and Pre-Medical Studies from Cornell University, and a certificate in pharmaceutical law and compliance from Seton Hall Law School’s Health Law Program.